Why We’re Here
We’re a biotechnology company with a big ambition: to transform the standard of care for autoimmune disease. By unlocking the innate power of natural killer (NK) cells — the immune system’s first responders — we’re working to eliminate malfunctioning B cells at the heart of some of medicine’s most devastating autoimmune conditions with the aim of alleviating suffering and delivering better health.
Scleroderma Has Been Her “Greatest Thief Yet Greatest Teacher”
Patient Fireside
Stephanie has survived decades by refusing to let the disease write the ending to her story. Her journey is one of resilience, hope and finding purpose.
Patient Story
A Scleroderma Survivor Discovers the Power of Self-Advocacy and the Joy in Helping Others
A Rheumatologist Who Listens, a Husband Who Truly Cares, and a Support Group to Guide Give Vernita Hope and Purpose
Despite the stiffness, the breathlessness, and the uncertainty that comes with a disease like scleroderma, Vernita has built a life supported by a carefully assembled toolbox: adaptation, faith, community, and service.
CEO Fireside
Bringing Cell Therapy Trials to the Community Clinic
At the American Society of Gene and Cell Therapy annual meeting last month, our CEO offered up a bold solution: bring next-generation cell therapy trials to community clinics.
Patient Story
STARING DOWN MYOSITIS AND KIDNEY CANCER
Love and Community Fuel Stephen’s Harrowing Survival Story
At the time of his dermatomyositis diagnosis, he was already deep into his PhD training as a neuroscientist. He was fascinated by the mysteries of the brain, never imagining the health mysteries of his own body he would have to solve.
Patient Fireside
Lupus Tried to Silence Her. Instead, She Became a Voice for Millions
Marisa shares her Lupus journey in a riveting and emotional fireside chat with her husband Mickey at Nkarta headquarters. Their story reflects personal experiences of individuals living with lupus.
Patient Story
The Lupus Power Couple
Emmitt and Shanell have a unique love story forged in the cauldron of lupus and their shared determination to use their diagnoses to support each another and inspire and advocate on behalf of the broader lupus community.
Patient Story
Dermatomyositis Took Her Old Life, But It Couldn’t Conquer Her Spirit
A disease that ravages muscle and skin made Melissa stronger and her skin thicker
Melissa’s day job checking patients into a busy ER demanded stamina, quick thinking and steadiness amidst the chaos. But then, like a looter in a riot, dermatomyositis ransacked her world, stealing precious things it had no right to take.
Patient Story
It’s a ‘Bad Day, Not a Bad Life’
A Scleroderma Survivor Finds Self-Love and Grace
Kimberly was hard on herself, but eventually she replaced self-judgment with self-love. Instead of seeing her body as betraying her, she now sees health episodes as her body trying to get her attention to ask for care.
Patient STory
The Warrior Who Taught Us Lupus Doesn’t Discriminate
Doctors told Emmitt he had stage 3 kidney disease caused by systemic lupus that had gone undiagnosed and untreated for years. Yet, even with a diagnosis in hand, the truth still didn’t fully land.
Q&A WITH DR. SHAWN ROSE
Autoimmune Innovation Merits a “Greater Sense of Urgency”
“I sat in the chair for four long hours with these large-bore needles that hurt like hell, hooked up to this noisy, clanking machine watching the blood flowing through. It was a harrowing experience.
Patients First
Why Stable Research Funding and Trade Policy Matter for Patients
On the Biotech Nation podcast, Nkarta CEO Paul Hastings discusses how research funding cuts and pharmaceutical tariff increases impact patients’ access to treatments and cures.
Patients First
Our Clinical Trial Promise
Instead of asking people with serious diseases to reconstruct their lives around our studies, drug developers should be striving to design our research around their lives. Read about what Nkarta is doing to make clinical trial opportunities more accessible and equitable.
Nature
Boosted Killer Cells Show
Promise For Autoimmune Disease
“Supercharged ‘natural killer’ cells could become a potent way to reset a disordered immune system,” according to one of the world's most prestigious scientific journals.
CEO Fireside
Changing What’s Possible in Autoimmune Treatment
Nkarta CEO Paul Hastings, a lifelong patient advocate, breaks down natural killer cell therapy and how it could potentially transform the therapeutic landscape in autoimmunity.